Issued Patents All Time
Showing 25 most recent of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12195524 | Multi-specific antigen binding molecules targeting HIV and methods of use | Brian Carr, Sheila B. Clancy, Craig S. Pace, Heather Stephenson, Nathan D. Thomsen | 2025-01-14 |
| 12071484 | Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein | Andrew Donald Nash, Arna Elizabeth Andrews, Kirsten Mae Edwards, Matthew HARDY, Con Panousis +1 more | 2024-08-27 |
| 11896648 | Interleukin-2 variant proteins fused to human IgG4 Fc and uses thereof | Sarah A. Gilmore, Hassan Javanbakht, Prasenjit Kumar Mukherjee | 2024-02-13 |
| 11555062 | Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer | Anthony Coyle, Thomas Thisted, Stacey Drabic, Luba Grinberg, Shabazz Novarra +3 more | 2023-01-17 |
| 11124582 | FLT3L-FC fusion proteins | Alexandre Ambrogelly, Brian Carr, Hon Man Hamlet Chu, Magdeleine S. Hung, Manu Kanwar +4 more | 2021-09-21 |
| 11098289 | Uricase sequences and methods of treatment | Andrew C. NYBORG | 2021-08-24 |
| 10975155 | CD40L-Fc fusion polypeptides and methods of use thereof | Stacey Drabic, Peter Emtage, Ronald Herbst | 2021-04-13 |
| 10883087 | Uricase sequences and methods of treatment | Andrew C. NYBORG | 2021-01-05 |
| 10106617 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Andrew Donald Nash, Louis Jerry Fabri, Dennis Zaller, William Strohl, Zhiqiang An | 2018-10-23 |
| 10000553 | CD40L-specific TN3-derived scaffolds and methods of use thereof | Anthony Coyle, Thomas Thisted, Stacey Drabic, Luba Grinberg, Shabazz Novarra +3 more | 2018-06-19 |
| 9777062 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Andrew Donald Nash, Louis Jerry Fabri, Dennis Zaller, William Strohl, Zhiqiang An | 2017-10-03 |
| 9371388 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Andrew Donald Nash, Louis Jerry Fabri, Dennis Zaller, William Strohl, Zhiqiang An | 2016-06-21 |
| 9212231 | TRAIL R2-specific multimeric scaffolds | Thomas Thisted, Jeffrey Swers, David Tice | 2015-12-15 |
| 9193793 | Antibodies against G-CSFR and uses thereof | Andrew Donald Nash, Arna Elizabeth Andrews, Kirsten Mae Edwards, Matthew HARDY, Con Panousis +1 more | 2015-11-24 |
| 9176129 | Protein scaffolds | Herren Wu, Jeffrey Swers, Benoy Chacko | 2015-11-03 |
| 8822644 | Method of treating cancer comprising a VEGF-B antagonist | Andrew Donald Nash, Felicity Meredith Dunlop, Louis Jerry Fabri, Pierre David Scotney | 2014-09-02 |
| 8633297 | Protein scaffolds | Herren Wu, Jeffrey Swers, Benoy Chacko | 2014-01-21 |
| 8613925 | Anti-IL-13Rα1 antibodies and their uses thereof | Andrew Donald Nash, Louis Jerry Fabri, Dennis Zaller, William Strohl, Zhiqiang An | 2013-12-24 |
| 8568722 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Andrew Donald Nash, Louis Jerry Fabri, Dennis Zaller, William Strohl, Zhiqiang An | 2013-10-29 |
| 8540977 | IL-11 muteins | — | 2013-09-24 |
| 8299027 | Method of modulating cell survival and reagents useful for same | Perry Francis Bartlett, Elizabeth Jane Coulson, Katrina Fieldew, Trevor Kilpatrick, Cheema Surindar | 2012-10-30 |
| 8221755 | Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1) | Felicity Meredith Dunlop, Andrew Donald Nash, Louis Jerry Fabri, Douglas Hilton, Nicos A. Nicola | 2012-07-17 |
| 8182814 | Methods of treating inflammatory airway conditions by inhibition of IL-11 activity | Andrew Donald Nash, Jack A. Elias | 2012-05-22 |
| 7993637 | IL-11 muteins | — | 2011-08-09 |
| 7919471 | Method of modulating cell survival and reagents useful for same | Perry Francis Bartlett, Elizabeth Jane Coulson, Katrina Fieldew, Trevor Kilpatrick, Cheema Surindar | 2011-04-05 |